Mangiferin and Its Traversal into the Brain

  • Dominika Zajac
  • Agnieszka Stasinska
  • Rene Delgado
  • Mieczyslaw Pokorski
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 756)


Mangiferin, the main active substance of the mango tree bark (Mangifera indica L.), is known for its use in natural medicine, not only as a health enhancing panacea or adjunct therapeutic, but also for brain functions improvement. In this context, we deemed it worthwhile to establish whether mangiferin could traverse into the brain after systemic administration; an essential piece of information for the rational use of a compound as a neurotherapeutic, remaining so far inconclusive regarding mangiferin. We addressed this issue by studying recoverability of mangiferin in membrane and cytosolic fractions of rat brain homogenates after its intraperitoneal administration in a dose of 300 mg/kg. We used three preparations of mangiferin of decreasing purity to find out whether its penetration to the brain could have to do with the possible presence of contaminants. The qualitative methods of thin-layered-chromatography and UV/VIS spectrophotometry were employed in this study. The results were clearly negative, as we failed to trace mangiferin in the brain fractions with either method, which makes it unlikely that the compound traverse the blood-brain barrier after being systemically administered. We conclude that it is improbable that mangiferin could act via direct interaction with central neural components, but rather has peripheral, target specific functions which could be secondarily reflected in brain metabolism.


Blood-brain barrier Brain homogenate Mangiferin Polyphenols Natural medicine 



This research was supported by the statutory budget of the Medical Research Center, Polish Academy of Sciences in Warsaw.

Conflicts of interest: The authors report no conflicts of interest in relation to this article.


  1. Beltrán, A. E., Alvarez, Y., Xavier, F. E., Hernanz, R., Rodriguez, J., Núñez, A. J., Alonso, M. J., & Salaices, M. (2004). Vascular effects of the Mangifera indica L. extract (Vimang®). European Journal of Pharmacology, 499, 297–305.PubMedCrossRefGoogle Scholar
  2. Bhattacharya, S. K., Sanyal, A. K., & Ghosal, S. (1972). Monoamine oxidase-inhibiting activity of mangiferin isolated from Canscora decussata. Naturwissenschaften, 59, 651.PubMedCrossRefGoogle Scholar
  3. Capote, R., Guardado, I., Novoa, H., Agüero, J., Paneque, A., & Sordo, L. (1998). Chemical-analytical characterization of aqueous extract of Mangifera indica L. Revista Cubana de Química, 10, 111–112.Google Scholar
  4. Cholbi, M. R., Paya, M., & Alcaraz, M. J. (1991). Inhibitory effect of phenolic compounds on CCL4-induced microsomal lipid peroxidation. Experientia, 472, 195–199.CrossRefGoogle Scholar
  5. Chopra, R. N., Nayar, S. L., & Chopra, I. C. (1956). Glossary of Indian medicinal plants (p. 49). New Delhi: CSIR.Google Scholar
  6. Garrido, G., González, D., Lemus, Y., Garcia, D., Lodeiro, L., Quintero, G., Delporte, C., Alberto, J., Núñez-Sellés, A. J., & Delgado, R. (2004). In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (Vimang®). Pharmacological Research, 50, 143–149.PubMedCrossRefGoogle Scholar
  7. Gómez-Zaleta, B., Ramírez-Silva, M. T., Gutierréz, A., González-Vergara, E., Güizado-Rodríguez, M., & Rojas-Hernández, A. (2006). UV/VIS, 1H, and 13C NMR spectroscopic studies to determine mangiferin pKa values. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 64, 1002–1009.CrossRefGoogle Scholar
  8. Gottlieb, M., Leal-Campanario, R., Campos-Esparza, M. R., Sánchez-Gómez, M. V., Alberdi, E., Arranz, A., Delgado-Garcıa, J. M., Gruart, A., & Matute, C. (2006). Neuroprotection by two polyphenols following excitotoxicity and experimental ischemia. Neurobiology of Disease, 23, 374–386.PubMedCrossRefGoogle Scholar
  9. Lai, L., Lin, L.-C., Lin, J.-H., & Tsai, T.-H. (2003). Pharmacokinetic study of free mangiferin in rats by microdialysis coupled with microbore high-performance liquid chromatography and tandem mass spectrometry. Journal of Chromatography. A, 987, 367–374.PubMedCrossRefGoogle Scholar
  10. Leiro, J., Arranz, J. A., Yanez, M., Ubeira, F. M., Sanmartin, M. L., & Orallo, F. (2004). Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin. International Journal of Immunopharmacology, 4, 763–778.CrossRefGoogle Scholar
  11. Martinez Sánchez, G., Candelario-Jalil, E., Giuliani, A., León, O. S., Sam, S., Delgado, R., & Núñez-Sellés, A. J. (2001). Mangifera indica L. (QF808) reduces ischaemia induced neuronal loss and oxidative damage in the gerbil brain. Free Radical Research, 35, 465–473.PubMedCrossRefGoogle Scholar
  12. Miura, T., Ichiki, H., Hashimoto, I., Iwamoto, N., Kato, M., Kubo, M., Ishihara, E., Komatsu, Y., Okada, M., Ishida, T., & Tanigawa, K. (2001). Antidiabetic activity of a xanthone compound, mangiferin. Phytomedicine, 8, 85–87.PubMedCrossRefGoogle Scholar
  13. Muruganandan, S., Lal, J., & Gupta, P. K. (2005a). Immunotherapeutic effects of mangiferin mediated by the inhibition of oxidative stress to activated lymphocytes, neutrophils and macrophages. Toxicology, 215, 57–68.PubMedCrossRefGoogle Scholar
  14. Muruganandan, S., Srinivasan, K., Gupta, S., Gupta, P. K., & Lal, J. (2005b). Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. Journal of Ethnopharmacology, 97, 497–501.PubMedCrossRefGoogle Scholar
  15. Núñez-Sellés, A., Vélez-Castro, H., Agüero-Agüero, J., González-González, J., Naddeo, F., De Simone, F., & Rastrelli, L. (2002). Isolation and quantitative analysis of phenolic antioxidants, free sugars, fatty acids and polyols from mango (Mangifera indica L.) stem bark aqueous decoction used in Cuba as nutritional supplement. Journal of Agricultural and Food Chemistry, 50, 762–766.PubMedCrossRefGoogle Scholar
  16. Pardo-Andreu, G. L., Delgado, R., Núñez-Sellés, A. J., & Vercesi, A. E. (2006a). Vimang® seems to act as an antioxidant by complexing iron ions, rendering them inactive or poorly active in the Fenton reaction. Phytotherapy Research, 20, 120–124.PubMedCrossRefGoogle Scholar
  17. Pardo-Andreu, G., Philip, S., Riaño, A., Sánchez, C., Viada, C., Núñez-Sellés, A. J., & Delgado, R. (2006b). Mangifera indica L. Vimang® protection against serum oxidative stress in elderly humans. Archives of Medical Research, 37, 158–164.PubMedCrossRefGoogle Scholar
  18. Pokorski, M., Delgado Hernandez, R., & Rekawek, A. (2010). Mangiferin: A neuroactive polyphenol. 4th International Congress of Pharmacology and Therapeutics; Havana, Cuba. Vaccine vial Monitors, 19(Suppl 2):161.Google Scholar
  19. Sánchez, G. M., Delgado, R., Núñez-Sellés, A. J., Davison, G. P., Garrido, G., & León, O. S. (2000a). Evaluation of the in vitro antioxidant activity of Mangifera indica L. extract (Vimang®). Phytotherapy Research, 14, 424–427.CrossRefGoogle Scholar
  20. Sánchez, G. M., Re, L., Giuliani, A., Núñez-Sellés, A. J., Davison, G. P., & León-Fernández, O. S. (2000b). Protective effects of Mangifera indica L. extract, mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice. Pharmacological Research, 42, 565–573.PubMedCrossRefGoogle Scholar
  21. Simpson, I. A., Appel, N. M., Hokari, M., Oki, J., Holman, G. D., Maher, F., Koehler-Stec, E. M., Vannucci, S. J., & Smith, Q. R. (1999). Blood-brain barrier glucose transporter: Effects of hypo- and hyperglycemia revisited. Journal of Neurochemistry, 72, 238–247.PubMedCrossRefGoogle Scholar
  22. Xu, X., De Pergola, G., Eriksson, P. S., Fu, L., Carlsson, B., Yang, S., Edén, S., & Björntorp, P. (1993). Postreceptor events involved in the up-regulation of beta-adrenergic receptor mediated lipolysis by testosterone in rat white adipocytes. Endocrinology, 132, 1651–1657.PubMedCrossRefGoogle Scholar
  23. Zajac, D., Matysiak, Z., Czarnocki, Z., & Pokorski, M. (2006). Membrane association of N-oleoyl-dopamine in rat brain. Journal of Physiology and Pharmacology, 57(Suppl 4), 403–408.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Dominika Zajac
    • 1
  • Agnieszka Stasinska
    • 1
  • Rene Delgado
    • 2
  • Mieczyslaw Pokorski
    • 1
  1. 1.Department of Respiratory ResearchMedical Research Center, Polish Academy of SciencesWarsawPoland
  2. 2.Laboratory of Molecular PharmacologyDrug Research and Development Center (CIDEM)HavanaCuba

Personalised recommendations